132791-92-5

Upstream product

• 137119-93-8 (R)-3-benzyloxy-1-(methanesulfonyloxy)tetradecane 
• 139629-59-7 1-O-allyl-2-deoxy-4,6-isopropylidene-2-(trifluoroacetamido)-α-D-glucopyranoside 
• 28715-21-1 (R)-3-hydroxytetradecanoic acid 
• 667462-08-0 2-trifluoroacetamido-2-deoxy-α,β-D-glucopyranose 
• 66-84-2 D-(+)-glucosamine hydrochloride 
• 139623-13-5 (R)-1,3-dihydroxytetradecane 
• 139623-15-7 (R)-3-benzyloxy-1-trityloxytetradecane 
• 139623-14-6 (R)-3-hydroxy-1-trityloxytetradecane 
• 132760-30-6 allyl 2-deoxy-2-trifluoroacetylamino-D-glucopyranoside 
• 139623-16-8 (R)-3-benzyloxy-1-hydroxytetradecane 

Downstream Products

• 132791-96-9 allyl 6-O-benzyloxymethyl-2-<(3R)-3-(benzyloxy)tetradecanamido>-3-O-<(3R)-3-(benzyloxy)tetradecanyl>-2-deoxy-4-O-diphenylphosphono-α-D-glucopyranoside 
• 139623-11-3 4,6-O-<(R)-benzylidene>-2-<(3R)-3-(benzyloxy)tetradecanamido>-3-O-<(3R)-3-(benzyloxy)tetradecanyl>-2-deoxy-α-D-glucopyranosyl dibenzyl phosphate 
• 132828-14-9 2-<(3R)-3-(benzyloxy)tetradecanamido>-3-O-<(3R)-3-(benzyloxy)tetradecanyl>-2-deoxy-4,6-O-isopropylidene-α-D-glucopyranosyl dibenzyl phosphate 
• 132791-95-8 allyl 6-O-benzyloxymethyl-2-<(3R)-3-(benzyloxy)tetradecanamido>-3-O-<(3R)-3-(benzyloxy)tetradecanyl>-2-deoxy-α-D-glucopyranoside 
• 139623-09-9 Allyl 4,6-O-<(3R)-benzylidene>-2-<(3R)-3-(benzyloxy)tetradecanamido>-3-O-<(3R)-3-(benzyloxy)tetradecanyl>-2-deoxy-α-D-glucopyranoside 
• 132832-52-1 Allyl 2-<(3R)-3-(benzyloxy)tetradecanamido>-3-O-<(3R)-3-(benzyloxy)tetradecanyl>-2-deoxy-4,6-O-isopropylidene-α-D-glucopyranoside 
• 132791-94-7 Allyl 2-<(3R)-3-(benzyloxy)tetradecanamido>-3-O-<(3R)-3-(benzyloxy)tetradecanyl>-2-deoxy-α-D-glucopyranoside 
• 137014-96-1 Acetic acid (2R,3S,4R,5R,6S)-6-allyloxy-3-benzyloxy-4-((R)-3-benzyloxy-tetradecyloxy)-5-(2,2,2-trifluoro-acetylamino)-tetrahydro-pyran-2-ylmethyl ester 
• 137014-97-2 N-[(2S,3R,4R,5S,6R)-2-Allyloxy-5-benzyloxy-4-((R)-3-benzyloxy-tetradecyloxy)-6-hydroxymethyl-tetrahydro-pyran-3-yl]-2,2,2-trifluoro-acetamide 
• 137014-95-0 Acetic acid (2R,3S,4R,5R,6S)-6-allyloxy-4-((R)-3-benzyloxy-tetradecyloxy)-3-hydroxy-5-(2,2,2-trifluoro-acetylamino)-tetrahydro-pyran-2-ylmethyl ester 
• 132760-25-9 2-deoxy-2-<(3R)-3-hydroxytetradecanamido>-3-O-<(3R)-3-hydroxytetradecanyl>-α-D-glucopyranosyl dihydrogen phosphate 
• 366805-12-1 (diphenylmethoxycarbonyl)methyl 2-[(R)-3-(benzyloxy)tetradecanamido]-3-O-[(R)-3-(benzyloxy)tetradecyl]-2-deoxy-α-D-glucopyranoside 
• 366805-09-6 (diphenylmethoxycarbonyl)methyl 2-[(R)-3-(benzyloxy)tetradecanamido]-3-O-[(R)-3-(benzyloxy)tetradecyl]-2-deoxy-4,6-O-isopropylidene-α-D-glucopyranoside 
• 366805-11-0 [(4aR,6S,7R,8R,8aS)-7-((R)-3-Benzyloxy-tetradecanoylamino)-8-((R)-3-benzyloxy-tetradecyloxy)-2,2-dimethyl-hexahydro-pyrano[3,2-d][1,3]dioxin-6-yloxy]-acetic acid 

Relevant academic research and scientific papers

Synthesis of lipid A type carboxymethyl derivatives with ether chains instead of ester chains and their LPS-antagonistic activities

Synthesis of lipid A type carboxymethyl derivatives having ether chains at both the C-3 and C-3′ positions and their LPS-antagonistic activities toward human U937 cells are described.

Synthesis of 2-deoxy-2-[(3R)-3-hydroxytetradecanamido]-3-O-[(3R)-3-hydroxytetradecan yl]-α-D-glucopyranosyl dihydrogen phosphate and 2-deoxy-2-[(3R)-3-hydroxy-tetradecanamido]-3-O-[(3R)-3-hydoxytetradecan yl]-4-O-phosphono-D-glucopyranose

Both a 3-O-alkyl lipid X analogue and its 4-O-phosphono isomer were synthesized from allyl 2-deoxy-4,6-O-isopropylidene-2-trifluoroacetamido-α-D-glucopyranoside. Both a 3-O-alkyl lipid X analogue and its 4-O-phosphono isomer were synthesized from allyl 2-deoxy-4,6-O-isopropylidene-2- trifluoroacetamido-α-D- glucopyranoside.